E-LIB Suche - Ergebnisse für: Cope, Andrew P.

1

Abatacept in individuals at high risk of rheumatoid arthrit..:

Cope, Andrew P ; Jasenecova, Marianna ; Vasconcelos, Joana C...
The Lancet. 403 (2024) 10429 - p. 838-849 , 2024

Link: https://doi.org/10.1016/..

2

P085 Implementing treat-to-target urate-lowering therapy du..:

Russell, Mark D ; Ameyaw-Kyeremeh, Louise ; Dell'Accio, Flora...
Rheumatology. 63 (2024) Supplement_1 - p. , 2024

Link: https://doi.org/10.1093/..

3

The influence of safety warnings on the prescribing of JAK ..:

Russell, Mark D ; Yang, Zijing ; Walter, Ben...
The Lancet Rheumatology. 6 (2024) 3 - p. e138-e139 , 2024

Link: https://doi.org/10.1016/..

4

Rheumatoid arthritis prevention in arthralgia: fantasy or r..:

van Steenbergen, Hanna W. ; Cope, Andrew P. ; van der Helm-van Mil, Annette H. M.
Nature Reviews Rheumatology. , 2023

Link: https://doi.org/10.1038/..

5

JAK inhibitors and the risk of malignancy: a meta-analysis ..:

Russell, Mark D ; Stovin, Christopher ; Alveyn, Edward...
Annals of the Rheumatic Diseases. 82 (2023) 8 - p. 1059-1067 , 2023

Link: https://doi.org/10.1136/..

6

Extracellular matrix rigidity modulates physical properties..:

Iliopoulou, Maro ; Bajur, Anna T. ; McArthur, Hannah C.W....
Biophysical Journal. , 2023

Link: https://doi.org/10.1016/..

7

Efficacy and safety of baricitinib or ravulizumab in adult ..:

Hall, Frances C ; Cheriyan, Joseph ; Cope, Andrew P...
The Lancet Respiratory Medicine. 11 (2023) 12 - p. 1064-1074 , 2023

Link: https://doi.org/10.1016/..

8

Rheumatoid Arthritis:

, In: Clinical Immunology,

Cope, Andrew P. - p. 678-692 , 2023

Link: https://doi.org/10.1016/..

9

List Of Contributors:

, In: Clinical Immunology,

Abraham, Roshini Sarah ; Afzali, Behdad ; Águeda, Ana... - p. xiii-xxv , 2023

Link: https://doi.org/10.1016/..

10

OA19 Incidence and management of inflammatory arthritis in ..:

Russell, Mark D ; Galloway, James B ; Andrews, Colm D...
Rheumatology. 62 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

11

Implementing treat-to-target urate-lowering therapy during ..:

Russell, Mark D ; Ameyaw-Kyeremeh, Louise ; Dell'Accio, Flora...
Rheumatology. 63 (2023) 8 - p. 2222-2229 , 2023

Link: https://doi.org/10.1093/..

12

OA08 JAK inhibitors and the risk of malignancy: a meta-anal..:

Stovin, Christopher ; Russell, Mark D ; Alveyn, Edward...
Rheumatology. 62 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

13

Gout incidence and management during the COVID-19 pandemic ..:

Russell, Mark D ; Massey, Jon ; Roddy, Edward...
The Lancet Rheumatology. 5 (2023) 10 - p. e622-e632 , 2023

Link: https://doi.org/10.1016/..

14

Incidence and management of inflammatory arthritis in Engla..:

Russell, Mark D ; Galloway, James B ; Andrews, Colm D...
The Lancet Rheumatology. 4 (2022) 12 - p. e853-e863 , 2022

Link: https://doi.org/10.1016/..

15

Humoral and cellular immunogenicity to a second dose of COV..:

Mahil, Satveer K ; Bechman, Katie ; Raharja, Antony...
The Lancet Rheumatology. 4 (2022) 1 - p. e42-e52 , 2022

Link: https://doi.org/10.1016/..